laboratory crp of amer hldgs
(LAB:Berlin)

Executive Profile*

Background*

Dr. Andrew J. Conrad, Ph.D., has been the Chief Scientific Officer of Laboratory Corp., since May 2008 and Executive Vice President since August 2009. Dr. Conrad serves as Clinical design Consultant of NovaRx Corporation. He founded the California Health and Longevity Institute (CHLI) where he serves as Chief Executive Officer, President and Laboratory Director. He co-founded National Genetics Institute in September 1991 and serves as its Chief Scientific Officer. Dr. ... Conrad serves as the Chief Scientific Officer of North Carolina Research Campus (NCRC) in Kannapolis, North Carolina. The primary focus of Dr. Conrad's research has been on the effects and manifestations of chronic viral illnesses as measured by the polymerase chain reaction (PCR). He also conducts research on the role of gene expression in cancer and is the responsible Head for the FDA Product License for The UltraQual Assay, a Nucleic Acid Test (NAT) for the detection of HIV-1, and HCV in plasma from large numbers of donors. He served as an Executive Director of Oncology and Pathology at US LABS, Inc. since December 2008. Dr. Conrad serves as Global Director of Esoteric Clinical Trials Service for Labcorp. since August 2005. He served as Chief Scientific Officer at Dole Food Company Inc. and Castle & Cooke, Inc. Dr. Conrad served as the Principal Investigator for FDA Product License Applications and was responsible for the laboratory component on nearly a dozen clinical trials involved in New Drug Applications to the FDA. Dr. Conrad has been a Director of Dole Food Company Inc. since July 2003. Dr. Conrad serves as a Director of Gensys Software, Inc. and NovaRx Corporation. Dr. Conrad has more than eighty-five publications in scientific and medical journals. Dr. Conrad graduated with a B.S. in Neurobiology and a PhD in Cell Biology from the University of California Los Angeles.

Report Data Issue

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Recently Viewed
LAB:GR	€77.28 EUR	-0.57

COMPETITOR COMPENSATION